Abstract
Antenatally detected sacrococcygeal teratoma (SCT) is a potentially
life-threatening condition. Its prenatal management remains a topic of
debate due to its association with fetal and maternal complications.
This review delves into various fetal approaches to SCT, elucidating the
roles of different procedures. Overall, fetal treatments are proposed to
highly selected patients, with severe complications of SCT who carry a
dismal prognosis and a high risk in utero death. No shared protocols for
patient and /or procedure selection exist thus overall management of
these patients is highly dependent on the team skills and facility
resources. Despite the general feeling that a prenatal diagnosis of SCT
involves a high mortality risk, this comprehensive review demonstrates
that advancements in fetal SCT treatment positively impact both fetal
and maternal outcomes.